Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
BMJ Open. 2024 May 8;14(5):e079782. doi: 10.1136/bmjopen-2023-079782.
Pregnancy and the postpartum period are increasingly recognised as sensitive windows for cardiometabolic disease risk. Growing evidence suggests environmental exposures, including endocrine-disrupting chemicals (EDCs), are associated with an increased risk of pregnancy complications that are associated with long-term cardiometabolic risk. However, the impact of perinatal EDC exposure on subsequent cardiometabolic risk post-pregnancy is less understood. The Environmental Reproductive and Glucose Outcomes (ERGO) Study was established to investigate the associations of environmental exposures during the perinatal period with post-pregnancy parental cardiometabolic health.
Pregnant individuals aged ≥18 years without pre-existing diabetes were recruited at <15 weeks of gestation from Boston, Massachusetts area hospitals. Participants completed ≤4 prenatal study visits (median: 12, 19, 26, 36 weeks of gestation) and 1 postpartum visit (median: 9 weeks), during which we collected biospecimens, health histories, demographic and behavioural data, and vitals and anthropometric measurements. Participants completed a postpartum fasting 2-hour 75 g oral glucose tolerance test. Clinical data were abstracted from electronic medical records. Ongoing (as of 2024) extended post-pregnancy follow-up visits occur annually following similar data collection protocols.
We enrolled 653 unique pregnancies and retained 633 through delivery. Participants had a mean age of 33 years, 10% (n=61) developed gestational diabetes and 8% (n=50) developed pre-eclampsia. Participant pregnancy and postpartum urinary phthalate metabolite concentrations and postpartum glycaemic biomarkers were quantified. To date, studies within ERGO found higher exposure to phthalates and phthalate mixtures, and separately, higher exposure to radioactive ambient particulate matter, were associated with adverse gestational glycaemic outcomes. Additionally, certain personal care products used in pregnancy, notably hair oils, were associated with higher urinary phthalate metabolite concentrations, earlier gestational age at delivery and lower birth weight.
Future work will leverage the longitudinal data collected on pregnancy and cardiometabolic outcomes, environmental exposures, questionnaires, banked biospecimens and paediatric data within the ERGO Study.
越来越多的人认识到怀孕和产后阶段是心血管代谢疾病风险的敏感时期。越来越多的证据表明,环境暴露,包括内分泌干扰化学物质(EDCs),与妊娠并发症风险增加有关,而这些并发症与长期心血管代谢风险有关。然而,围产期 EDC 暴露对产后心血管代谢风险的影响还不太清楚。环境生殖和葡萄糖结局(ERGO)研究旨在调查围产期环境暴露与产后父母心血管代谢健康之间的关联。
年龄≥18 岁、无孕前糖尿病的孕妇在马萨诸塞州波士顿地区医院妊娠<15 周时被招募。参与者完成了≤4 次产前研究访视(中位数:12、19、26、36 周妊娠)和 1 次产后访视(中位数:9 周),在此期间,我们收集了生物样本、健康史、人口统计学和行为数据以及生命体征和人体测量数据。参与者完成了产后禁食 2 小时 75g 口服葡萄糖耐量试验。临床数据从电子病历中提取。正在进行(截至 2024 年)的扩展产后随访在每年进行,采用类似的数据收集方案。
我们共招募了 653 例独特的妊娠,并在分娩后保留了 633 例。参与者的平均年龄为 33 岁,10%(n=61)发生了妊娠期糖尿病,8%(n=50)发生了子痫前期。量化了参与者妊娠和产后尿液邻苯二甲酸酯代谢物浓度和产后血糖生物标志物。迄今为止,ERGO 内的研究发现,较高的邻苯二甲酸酯和邻苯二甲酸酯混合物暴露,以及分别较高的放射性环境颗粒物暴露与不良的妊娠血糖结局有关。此外,妊娠期间使用的某些个人护理产品,特别是发油,与较高的尿液邻苯二甲酸酯代谢物浓度、更早的分娩孕周和较低的出生体重有关。
未来的工作将利用 ERGO 研究中收集的关于妊娠和心血管代谢结局、环境暴露、问卷、生物样本库和儿科数据的纵向数据。